NIH VideoCast - NIH-FDA COVID 19 SIG Lecture Series: RECOVER Treating Long COVID: Future Clinical Trials Informed by Pathobiology and Symptoms by Jeanne Marrazzo, M.D., M.P.H.

Skip Navigation

NIH-FDA COVID 19 SIG Lecture Series: RECOVER Treating Long COVID: Future Clinical Trials Informed by Pathobiology and Symptoms by Jeanne Marrazzo, M.D., M.P.H.

0 seconds of 0 secondsVolume 90%

00:25

00:00

00:00

446 Views

Air date:	Thursday, September 26, 2024, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 446 (300 Live, 146 On-demand)
Category:	COVID-19
Runtime:	01:01:55
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The COVID-19 SIG lecture series facilitates communication of the ongoing scientific research to understand SARS-CoV-2 and treat COVID-19. Invited speakers share the latest research on a broad range of topics, including clinical findings, therapeutics, basic biology, epidemiology, and public health research. This lecture series runs from October through June. Dr. Marrazzo began her tenure as the sixth NIAID Director in the fall of 2023. She oversees a $6.6 billion budget that supports research to advance the understanding, diagnosis, treatment and prevention of infectious, immunologic, and allergic diseases. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health. Dr. Marrazzo’s research in discovery and implementation science has focused on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception; prevention of HIV infection using biomedical interventions, including preexposure prophylaxis (PrEP) and microbicides; and the pathogenesis and management of bacterial vaginosis (BV), sexually transmitted diseases in HIV-infected persons, and management of antibiotic resistance in gonorrhea. She is the author, coauthor, or editor of more than 250 scientific publications. LECTURE SUMMARY: Dr. Marrazzo’s presentation will outline the plans for Recover-Treating Long COVID (RECOVER-TLC) and report out on the RECOVER-TLC -Navigating the Pathway Forward Workshop that was held earlier this week. This talk will also review some of the latest scientific concepts driving the potential prioritization of interventions for Long COVID. RECOVER-TLC is a new clinical trials program designed to evaluate pharmacologic and non-pharmacologic agents to treat Long COVID and provide treatments rapidly to health care providers and their patients. This program, led by NIAID working collaboratively with NINDS, NHLBI, and other ICs, will use platform trial designs using new protocol templates for rapid addition of other interventions reflecting the latest scientific findings. RECOVER-TLC will build on ongoing RECOVER observational cohort and clinical trial findings; while ensuring transparency, data sharing, and ongoing engagement with the scientific, industry, and patient communities. For more information go to https://www.niaid.nih.gov/research/covid-19-sig

Author:	Jeanne Marrazzo, M.D., M.P.H.

CIT Live ID:	55210
Permanent link:	https://videocast.nih.gov/watch=55210

Related Videos...